Yun Xiang Zhu
Corporate Officer/Principal bei CANBRIDGE PHARMACEUTICALS INC.
Profil
Yun Xiang Zhu, Senior Director at Genzyme Corp.
from 2001 to 2018, Research Associate at Fudan University from 1988 to 1990, and Senior Vice President at Beijing Shenogen Pharma Group Ltd.
from 2018 to 2020.
Education: Undergraduate degree from Zhejiang University in 1984, graduate degree from Shanghai Institute of Materia Medica Chinese Academy of Sci in 1988, and doctorate degree from The University of Miami Leonard M.
Miller School of Medicine in 1996.
Aktive Positionen von Yun Xiang Zhu
| Unternehmen | Position | Beginn |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Corporate Officer/Principal | 15.09.2020 |
Ehemalige bekannte Positionen von Yun Xiang Zhu
| Unternehmen | Position | Ende |
|---|---|---|
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01.09.2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.05.2018 |
| Fudan University | Corporate Officer/Principal | 01.08.1990 |
Ausbildung von Yun Xiang Zhu
| Zhejiang University | Undergraduate Degree |
| Shanghai Institute of Materia Medica Chinese Academy of Sci | Graduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
